Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126626841 | 12662684 | 1 | I | 20160815 | 20160818 | 20160818 | EXP | JP-ROCHE-1813783 | ROCHE | TOMINAGA T, NONAKA T, SUMIDA Y, HIDAKA S, SAWAI T AND NAGAYASU T. EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY FOR ELDERLY PATIENTS WITH LYMPH NODE-POSITIVE COLORECTAL CANCER. WORLD JOURNAL OF SURGICAL ONCOLOGY 2016 JUL 28;14 (1):1-7. | 0.00 | Y | 0.00000 | 20160818 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126626841 | 12662684 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | ||||||||||
| 126626841 | 12662684 | 2 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Unknown | U | 0 | ||||||||||
| 126626841 | 12662684 | 3 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 126626841 | 12662684 | 4 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | U | 0 | ||||||||||
| 126626841 | 12662684 | 5 | SS | GIMERACIL/OTERACIL POTASSIUM/TEGAFUR | GIMERACILOTERACILTEGAFUR | 1 | Unknown | U | 0 | ||||||||||
| 126626841 | 12662684 | 6 | SS | TEGAFUR/URACIL | TEGAFURURACIL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126626841 | 12662684 | 1 | Colorectal cancer |
| 126626841 | 12662684 | 2 | Colorectal cancer |
| 126626841 | 12662684 | 3 | Colorectal cancer |
| 126626841 | 12662684 | 4 | Colorectal cancer |
| 126626841 | 12662684 | 5 | Colorectal cancer |
| 126626841 | 12662684 | 6 | Colorectal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126626841 | 12662684 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126626841 | 12662684 | Anaphylactic reaction | |
| 126626841 | 12662684 | Decreased appetite | |
| 126626841 | 12662684 | Diarrhoea | |
| 126626841 | 12662684 | Fatigue | |
| 126626841 | 12662684 | Hepatic function abnormal | |
| 126626841 | 12662684 | Hyperbilirubinaemia | |
| 126626841 | 12662684 | Leukoencephalopathy | |
| 126626841 | 12662684 | Neutropenia | |
| 126626841 | 12662684 | Palmar-plantar erythrodysaesthesia syndrome | |
| 126626841 | 12662684 | Perforation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |